CRINETICS PHARMACEUTICALS INC. - COMMON STOCK

Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement

28 فبراير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

14 فبراير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces February 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 فبراير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 يناير 2024 16:33:42 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

03 يناير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome

18 ديسمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces December 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 ديسمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in Upcoming Investor Conferences

20 نوفمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 نوفمبر 2023 17:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

07 نوفمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 أكتوبر 2023 17:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023

20 سبتمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

12 سبتمبر 2023 22:26:42 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

11 سبتمبر 2023 16:01:22 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 سبتمبر 2023 06:00:48 بحسب Nasdaq GlobeNewswire

Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-1 Study Evaluating Treatment of Patients with Acromegaly

10 سبتمبر 2023 10:00:04 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 أغسطس 2023 17:34:32 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

08 أغسطس 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly

31 يوليو 2023 08:01:44 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 يوليو 2023 16:19:04 بحسب Nasdaq GlobeNewswire